BioAtla Inc. (BCAB) PT Lowered to $7 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Price: $3.09 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
H.C. Wainwright analyst Arthur He lowered the price target on BioAtla Inc. (NASDAQ: BCAB) to $7.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James
- Zscaler (ZS) PT Raised to $200 at TD Cowen
- JD.com, Inc (JD) PT Lowered to $30 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
